GLUCOSENTIENT INC
CHAMPAIGN, IL · Founded 2011 · CIK 0001560821 · Medtech · Private
Therapeutic drug monitoring (TDM) platform for anti-TB drugs using modified blood glucose meter hardware to measure drug concentrations in blood
glucosentient.com →- Grants
- $3.3M
- 9 awards
- Sector median: 1
- Raised
- $60K
- 1 Form D · Oct 2012
- 167 months since last filing
- Contracts
- $1.6M
- 2 awards · Health and Human S
- #247 of 4531 in medtech
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2012201420162018202020222024
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $60,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Developing an Affordable and Pocketable POC Device for Monitoring Lithium and Sodium in Patients with Bipolar Disorder | $210,971 | |
| Federal grant | Department of Health and Human Services · Phase I · Developing an Affordable and Pocketable POC Device for Monitoring Lithium and Sodium in Patients with Bipolar Disorder | $210,971 | |
| Federal contract | Department of Health and Human Services · Igf::ot::igf Tele-monitoring For Infectious Diseases: A Remote System For Assessing Patient Parameters And Specimen Analysis | $224,751 | |
| Federal grant | Department of Health and Human Services · Phase I · A rapid and portable test for home monitoring of phenylalanine levels by patients with phenylketonuria using a blood glucose meter | $223,500 | |
| Federal grant | Department of Health and Human Services · Phase I · A rapid and portable test for home monitoring of phenylalanine levels by patients with phenylketonuria using a blood glucose meter | $223,500 | |
| Federal grant | Department of Health and Human Services · Phase I · Point-of-care assay using Blood Glucose Meter for early warning of chronic lung rejection | $225,000 | |
| Federal contract | Department of Health and Human Services · Igf::ot::igf Assay Optimization And Adaptation For A Customized Meter Development | $1,408,787 | |
| Federal grant | Department of Health and Human Services · Phase I · Rapid point-of-care test for hepatitis C virus (HCV) core antigen to screen active HCV infection | $224,018 | |
| Federal grant | Department of Health and Human Services · Phase I · A point-of-care salivary cytokine test for early detection of oral cancer | $269,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Improving the effectiveness of anti-tuberculosis drugs by developing a point-of-care therapeutic drug monitoring system for areas with limited medical resources | $265,773 |
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 244 | INFRAREDX INC | $1.7M | $57M |
| 245 | NEW HEALTH SCIENCES, INC. | $1.7M | — |
| 246 | ALA SCIENTIFIC INSTRUMENTS INC | $1.6M | — |
| 247 | GLUCOSENTIENT INC | $1.6M | $60K |
| 248 | IMAGINAB, INC. | $1.6M | $36M |
| 249 | Pulmonx Corp | $1.6M | $170M |
| 250 | IMPULSE TECHNOLOGY LLC | $1.5M | $300K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Yi LuDirector · Promoter
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.